NASDAQ:QNTM - Nasdaq - CA74764Y2050 - Common Stock - Currency: USD
NASDAQ:QNTM (3/7/2025, 8:00:01 PM)
4.62
+0.12 (+2.67%)
The current stock price of QNTM is 4.62 USD. In the past month the price decreased by -68.14%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 66.89 | 824.51B | ||
JNJ | JOHNSON & JOHNSON | 16.69 | 401.33B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 26.18 | 386.95B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 21.41 | 240.28B | ||
MRK | MERCK & CO. INC. | 12.39 | 239.09B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 14.56 | 228.26B | ||
PFE | PFIZER INC | 8.59 | 151.49B | ||
SNY | SANOFI-ADR | 14.24 | 148.55B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 53.59 | 123.97B | ||
GSK | GSK PLC-SPON ADR | 8.29 | 81.62B | ||
ZTS | ZOETIS INC | 28.78 | 76.29B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 33.71 | 47.88B |
Quantum BioPharma Ltd is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The firm is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.
QUANTUM BIOPHARMA LTD
First Canadian Place, 100 King Street West, Suite 4000
TORONTO ONTARIO CA
Employees: 10
Company Website: https://www.fsdpharma.com/
Investor Relations: http://www.fsdpharma.com/investors
Phone: 14168548884
The current stock price of QNTM is 4.62 USD. The price increased by 2.67% in the last trading session.
The exchange symbol of QUANTUM BIOPHARMA LTD is QNTM and it is listed on the Nasdaq exchange.
QNTM stock is listed on the Nasdaq exchange.
QUANTUM BIOPHARMA LTD (QNTM) has a market capitalization of 10.63M USD. This makes QNTM a Nano Cap stock.
QUANTUM BIOPHARMA LTD (QNTM) currently has 10 employees.
QUANTUM BIOPHARMA LTD (QNTM) has a support level at 4.38 and a resistance level at 4.9. Check the full technical report for a detailed analysis of QNTM support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
QNTM does not pay a dividend.
QUANTUM BIOPHARMA LTD (QNTM) will report earnings on 2025-03-26.
The outstanding short interest for QUANTUM BIOPHARMA LTD (QNTM) is 16.1% of its float. Check the ownership tab for more information on the QNTM short interest.
ChartMill assigns a technical rating of 1 / 10 to QNTM.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to QNTM. The Buy consensus is the average rating of analysts ratings from 7 analysts.